Format

Send to

Choose Destination
Mol Carcinog. 2016 Dec;55(12):2089-2094. doi: 10.1002/mc.22453. Epub 2016 Jan 12.

Mitochondrial DNA copy number in whole blood and glioma risk: A case control study.

Author information

1
Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas.
2
Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.

Abstract

Alterations in mitochondrial DNA (mtDNA) copy number are observed in human gliomas. However, whether variations in mtDNA copy number in whole blood play any role in glioma carcinogenesis is still largely unknown. In current study with 395 glioma patients and 425 healthy controls, we intended to investigate the association between mtDNA copy number in whole blood and glioma risk. Overall, we found that levels of mtDNA copy number were significantly higher in glioma cases than healthy controls (mean: 1.48 vs. 1.32, P < 0.01). In both cases and controls, levels of mtDNA copy number were inversely correlated with age (P < 0.01, respectively). And in cases, newly diagnosed, glioblastoma (GBM), and high grade glioma patients had significantly lower mtDNA copy number than their counterparts (P = 0.02, P < 0.01, and P = 0.04, respectively). In the multivariate analysis, elevated mtDNA copy number levels were associated with a 1.63-fold increased risk of glioma (adjusted odds ratio (OR) = 1.63, 95% confidence interval (CI) = 1.23-2.14). In further quartile analysis, study subjects who had highest levels of mtNDA copy number had 1.75-fold increased risk of gliomas (adjOR = 1.75, 95%CI = 1.18-2.61). In brief, our findings support the role of mtDNA copy number in the glioma carcinogenesis.

KEYWORDS:

cancer risk; glioma; mitochondrial DNA copy number

PMID:
26756431
DOI:
10.1002/mc.22453
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center